The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Calcification of the Aortic Valve in the Dialyzed Patient
Abstract
Cardiovascular disease is the leading cause of mortality in patients with end-stage renal disease (ESRD), with cardiac disease alone accounting for 40% of all deaths. Ischemic heart disease, heart failure, and cardiomyopathy are the most frequent causes of cardiac death (1), but valvular abnormalities are also common in these patients and may cause significant morbidity and mortality (2,3,4,5,6,7,8,9). In principle, the origin of valvular alterations can be congenital, infectious, or dystrophic (10). The majority of valvular lesions observed in ESRD patients are acquired, mostly secondary to dystrophic calcification of the valvular annulus and the leaflets. The mitral and aortic valves are the preferential sites for dystrophic valvular calcification in ESRD. For a long time, the calcification of the aortic valve and annulus was considered an age-associated degenerative lesion with little functional importance. Recent studies of elderly subjects in the general population have shown, however, that aortic-valve sclerosis carries an increased risk of death from cardiovascular disease and myocardial infarction (11). In ESRD patients, aortic-valve sclerosis and calcification may progress rapidly and calcific aortic stenosis (AS) develops frequently (7,9,12). With the age of patients treated by dialysis increasing constantly, the prevalence of aortic valve calcification and its complications will increase in parallel. Epidemiology Prevalence and Incidence In the general population, sclerosis, thickening, or calcification of the aortic valves in the absence of left ventricular (LV) outflow obstruction is observed principally in the elderly. It affects 20 to 30% of the population over 65 yr of age, and functionally relevant AS is present in about 2% (11,13,14). The prevalence of aortic sclerosis and AS increases with age and is found in 48 to 53% and 4 to 5%, respectively, of adults over 85 yr of age (11). In ESRD patients, the prevalence of aortic valve calcifications is also 28 to 55%, but it occurs 10 to 20 yr earlier than in the general population (2,6,7,9). ESRD patients with aortic valve calcification are older than those with noncalcified valves. As in the general population, the prevalence of hemodynamically asymptomatic aortic valve calcification increases with age. Hemodynamically significant AS is found in 3 to 9% of patients (2,9,15), and the incidence of symptomatic AS is 3.3% per year in hemodialyzed patients (9). In a large multicenter survey of 230 chronic dialysis centers in France (7), the annual incidence of severe valvular heart disease (mitral and aortic combined) was 15 to 19 cases per 10,000 dialyzed patients. Valve calcification in the absence of known preexisting valvular disease accounted for 69% of all cases of severe valvulopathy. Of the patients with calcific valvular disease, 51% had AS. Etiology and Pathophysiology Acquired calcification and/or stenosis in ESRD is usually infectious or degenerative in origin (7). In the early stages, the anatomy of these two conditions is rather specific, but the specificity is lost when progressive calcification supervenes. Valvular disease of infectious origin has decreased in frequency, and today the majority of calcific aortic valve disease in the general population is degenerative (senile) in origin. In degenerative aortic calcification, the lesions are first seen at the site of valve insertion. They extend in the direction of the cusps. Commisural fusion is present only in advanced stages when calcium deposits protrude and fuse the valve leaflets (10). Aortic calcification in ESRD patients is almost constantly associated with widespread calcification of the myocardium, mitral valves, aorta, and large- or medium-sized arteries, including coronary arteries (6). The degenerative (wear and tear) etiology appears to underlie the dystrophic calcification of aortic valves (10). Aortic valves are submitted to cyclic mechanical stress. The stress is related to pressure gradients and turbulent blood flow resulting from the high acceleration rate and peak velocity when blood flows through the aortic valve. Apart from cyclic opening and closure of the valves, high frequency vibration of the leaflets is produced by turbulent flow. Over the lifespan, the repetitive mechanical stress causes fatigue and rearrangement of bioelastomers, leading to microfractures in the biomaterials ultimately resulting in fibrosis and calcification. Calcification further increases peak ejection velocity and causes turbulent blood flow, thus creating a vicious cycle. Renal failure and dialysis superimpose futher pathomechanisms. This conclusion is supported by the observation that a correlation is found between duration of hemodialysis treatment and presence of heart valve calcification (4,5) (Table 1).Table 1: Logistic regressionaESRD promotes valvular disease by hemodynamic and biochemical mechanisms. The blood flow velocity and the degree of turbulence across the aortic valve ar
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029
Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves
Olsson, M., Thyberg, J., & Nilsson, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1218 · Cited by 417
Cited by
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Schäfer, C., Heiss, A., Schwarz, A., Westenfeld, R., Ketteler, M., Floege, J., Müller-Esterl, W., Schinke, T., & Jahnen-Dechent, W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17202 · Cited by 924
Li, X., Yang, H.-Y., & Giachelli, C. M. (2006) · Circulation Research · doi:10.1161/01.res.0000216409.20863.e7 · Cited by 457
Metadata
- Authors
- LONDON, G. M., PANNIER, B., MARCHAIS, S. J., & GUERIN, A. P.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2000-04
- Volume
- 11
- Issue
- 4
- Pages
- 778-783
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2106275671
- Cited by
- 185
- References
- 2
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calcification of the Aortic Valve in the Dialyzed Patient. https://app.cochat.ai/papers/10.1681/asn.v114778
- The paper
- LONDON, G. M., PANNIER, B., MARCHAIS, S. J., & GUERIN, A. P. (2000). Calcification of the Aortic Valve in the Dialyzed Patient. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v114778
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.